N Engl J Med · 2012
Safety and activity of anti-PD-L1 antibody in patients with advanced cancer
Brahmer JR, Tykodi SS, Chow LQ, Hwu WJ, Topalian SL, Hwu P, Drake CG, Camacho LH, Kauh J, Odunsi K, Pitot HC, Hamid O, Bhatia S, Martins R, Eaton K, Chen S, Salay TM, Alaparthy S, Grosso JF, Korman AJ, Parker SM, Agrawal S, Goldberg SM, Pardoll DM, Gupta A, Wigginton JM.
Show affiliations
- Brahmer JR — Johns Hopkins University School of Medicine and the Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD 21231, USA.
37 read3 want to readRigor 3.2Novelty 3.4Impact 3.0Reprod. 3.1
Most-cited papers citing this
- Mol Cancer · 2025 · cited by 2
- Front Immunol · 2025 · cited by 2
- Cancer Immunol Res · 2025 · cited by 2
- Cancer Res Commun · 2026 · cited by 1
- Immunology · 2026 · cited by 1
Log in to like, log, and share thoughts on this paper.
Discussion
Share your thoughts above to start a thread. Constructive feedback only — reply to and like others’ posts.
0
0
0
0
0
0
0
0